SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Based Chad

Based Chad is trending as community members highlight its relative strength compared to other memecoins amid market dips, emphasizing its diamond-handed community and unique buyback mechanisms. Discussions also suggest a potential connection to Coinbase, with executives reportedly holding the token and the meme gaining traction on the platform. The community anticipates further growth, pointing to upcoming video game integrations and staking opportunities.

Codatta

XNY (Codatta) is trending amid discussions about its role in powering AI's data future and recent exchange listings. The community highlights its potential for data contributors to earn royalties and its strong performance relative to Bitcoin in the current market. Some traders are pointing to bullish chart patterns and anticipating a breakout.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad (MON) is trending as the community discusses its potential as a high-speed, EVM-compatible blockchain, with some comparing it to early Ethereum and Solana. The community is focused on its Coinbase listing and potential for staking rewards, while also debating its market cap and long-term viability. Discussions also include speculation around future exchange listings and potential partnerships.

The Bank of Nova Scotia engages in the provision of financial products and services including personal, commercial, corporate, and investment banking. It operates through the following segments: Canadian Banking, International Banking, Global Wealth Management, Global Banking and Markets, and Other. The company was founded on March 30, 1832 and is headquartered in Toronto, Canada.

Bank Of Nova Scotia

Bank of Nova Scotia is trending as investors discuss the Canadian bank's positioning amidst potential interest rate changes and a recent strategic investment in KeyCorp. Community sentiment leans towards optimism, noting undervaluation and potential for growth, particularly with the upcoming earnings report and the bank's strong dividend yield. Discussions also involve the bank's strategic shifts in Latin America and North America and how these moves may impact future performance.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

WBD is trending amid speculation around potential bids from Comcast, Netflix and Paramount, with some community members discussing the likelihood of a deal being reached by the end of the year. Community members are debating the potential bid prices and who might win the bidding war, with many speculating on potential offers from other major players. Some traders are taking bullish positions, while others express skepticism about management and debt.

Columbus Circle Capital Corp. I operates as a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which refer to throughout this prospectus as initial business combination. The company was founded in June 2024 and is headquartered in New York, NY.

Columbus Circle Capital Corp I - Ordinary Shares - Class A

BRR is trending as chatter swirls around its upcoming merger vote and potential exposure to Bitcoin, with some highlighting the involvement of Eric Jackson and Anthony Pompliano. The community is speculating on a potential short squeeze and the impact of amendments to the deal, with excitement building for a possible rally.

Kohl's Corp. engages in the operation of family-oriented department stores. Its business line includes apparel, footwear, and accessories for women, men, and children, home products, beauty products, and accessories. The stores generally carry a consistent merchandise assortment with some differences attributable to regional preferences. The company was founded in 1962 and is headquartered in Menomonee Falls, WI.

Kohl`s Corp.

Kohl's Corp

Kohl's is trending amid community discussion around its potential for a short squeeze and overall undervaluation, with some highlighting the company's real estate assets. Bullish sentiment is growing as some traders are pointing to technical indicators and awaiting the next earnings report, while bears cite concerns about debt and declining sales.

Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. It currently provides three proprietary travel vaccines: IXIARO, DUKORAL, and IXCHIQ. The IXIARO is an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis in adults, adolescents, children, and infants aged two months and older. The DUKORAL is a drinkable vaccine that helps prevent diarrhea caused by heat-labile toxin-producing ETEC, as well as cholera. The IXCHIQ is a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also offers additional vaccines, including VLA1553, VLA15, VLA160, VLA200, VLA1601 and others. Valneva was founded on May 28, 2013 and is headquartered in Saint-Herblain, France.

Valneva SE - ADR

Valneva is trending due to positive Phase 2 booster results for its Lyme disease vaccine, developed in partnership with Pfizer, fueling speculation about a potential buyout. The community is focused on the significant revenue potential of the Lyme vaccine and anticipating Phase 3 trial data. Some investors express caution, referencing past setbacks, while others see the current low trading volume as an opportunity for exponential gains upon positive news.

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Elevance Health Inc

Elevance Health ($ELV) is trending as traders discuss options activity and potential upside, while analysts update ratings. Community members are weighing in on the company's valuation and its position relative to competitors within the managed care sector amid political and economic uncertainty impacting the broader healthcare landscape.

American Eagle Outfitters, Inc. is a multi-brand specialty retailer, which offers an assortment of apparel and accessories for men and women under the American Eagle Outfitters brand, and intimates, apparel and personal care products for women under the Aerie brand. The firm operates stores in the United States, Canada, Mexico, Hong Kong, China and the United Kingdom. It also acquired two emerging brands to complement its existing brands, Tailgate, a vintage sports-inspired apparel brand, and Todd Snyder New York, a premium menswear brand. The company was founded in 1977 and is headquartered in Pittsburgh, PA.

American Eagle Outfitters Inc.

American Eagle Outfitters, Inc.

American Eagle Outfitters is trending due to strong earnings and guidance, driven in part by successful marketing campaigns featuring celebrities like Sydney Sweeney. The community is discussing the potential for a short squeeze and further gains, as well as the company's ability to capitalize on upcoming sales opportunities. Broader context includes positive sentiment around the retail sector and the potential impact of celebrity endorsements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pacific Biosciences of California (NASDAQ:PACB) Shares Down 8.2% - Here's What Happened

Pacific Biosciences of California (NASDAQ:PACB) Shares Down 8.2% - Time to Sell...

Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year?

Here is how Artivion (AORT) and Pacific Biosciences of California (PACB) have performed compared to their sector so far this year.

Pacific Biosciences of California, Inc. $PACB Shares Sold by Edmond DE Rothschild Holding S.A.

Edmond DE Rothschild Holding S.A. decreased its position in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 38.8% during the 2nd quarter, according to the company in...

Pacific Biosciences of California (NASDAQ:PACB) Hits New 52-Week High - What's Next?

Pacific Biosciences of California (NASDAQ:PACB) Sets New 1-Year High - Here's Why...

Pacific Biosciences of California (NASDAQ:PACB) Stock Price Up 7% - Still a Buy?

Pacific Biosciences of California (NASDAQ:PACB) Shares Up 7% - Should You Buy...

Pacific Biosciences of California (NASDAQ:PACB) Shares Cross Above 200 Day Moving Average - Here's Why

Pacific Biosciences of California (NASDAQ:PACB) Stock Crosses Above 200 Day Moving Average - Should You Sell...

Top 3 Genomics Stocks to Consider for Your Portfolio

Genomics gains momentum as EDIT, SANA, and PACB emerge as standout picks amid rapid advances in sequencing and gene editing.

Pacific Biosciences (PACB) Upgraded to Buy: Here's Why

Pacific Biosciences (PACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Pacific Biosciences of California (NASDAQ:PACB) Stock Price Expected to Rise, Piper Sandler Analyst Says

Piper Sandler boosted their price target on Pacific Biosciences of California from $1.50 to $2.00 and gave the stock a "neutral" rating in a report on Tuesday...

Stephens Issues Positive Forecast for Pacific Biosciences of California (NASDAQ:PACB) Stock Price

Stephens increased their price objective on Pacific Biosciences of California from $1.80 to $2.00 and gave the stock an "overweight" rating in a report on Monday...

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Pacific Biosciences of California Inc

$AMZN

$MSFT

$GOOGL

$ORCL

Which cloud infrastructure stock offers the best long-term opportunity right now?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.15	--	--	N/A
Q3 '25	-$0.15	-$0.13	14.01%	BEAT
Q2 '25	-$0.17	-$0.14	18.13%	BEAT
Q1 '25	-$0.19	-$1.44	-649.71%	MISSED
Q4 '24	-$0.19	$0.01	105.26%	BEAT

PACB
Pacific Biosciences of California Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q3 '25

Historical Earnings

Latest PACB News

PACBPacific Biosciences of California Inc